Home » Topics » Regulatory

Regulatory
RSS

Beta3-adrenoceptor agonists now claimed for inhibiting uterine contractions

May 22, 2000

Clinical data support equivalence of Gengraf and Neoral; Gengraf approved by FDA

May 19, 2000

Major approval obtained for Mylotarg, the first antibody-targeted chemotherapy product

May 19, 2000

FDA denies approval for Refludan in acute coronary syndrome

May 19, 2000

Lilly's Evista receives additional approval in E.U. for the treatment of osteoporosis

May 19, 2000

Pantoprazole now available for more uses

May 19, 2000

Use of RAR antagonists or inverse agonists as male contraceptives described by Allergan

May 18, 2000

FDA-approved slower Topamax titration schedule improves tolerability

May 18, 2000

Ligand reports data from two trials of Targretin gel formulation in CTCL

May 17, 2000

FDA reviews Thymoglobulin IND for evaluation in MDS patients

May 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.